Literature DB >> 20881939

Angiogenic growth factors correlate with disease severity in young patients with autosomal dominant polycystic kidney disease.

Berenice Y Reed1, Amirali Masoumi, Elwaleed Elhassan, Kim McFann, Melissa A Cadnapaphornchai, David M Maahs, Janet K Snell-Bergeon, Robert W Schrier.   

Abstract

Renal cysts, pain, and hematuria are common presentations of autosomal dominant polycystic kidney disease (ADPKD) in children. Renal function, however, is typically preserved in these patients despite increased renal volume. Since angiogenesis has been implicated in promotion of renal cyst growth in ADPKD, we measured the serum level of various angiogenic factors and early renal structural changes and cardiovascular parameters in 71 patients with ADPKD, with a mean age of 16 years. Renal structure and left ventricular mass index were measured by magnetic resonance imaging or by echocardiogram. Renal function was assessed by creatinine clearance and urinary protein excretion. Serum growth factor levels were measured by enzyme-linked immunosorbent assay. Because of skewed distributions, the various parameters are reported as log(10). Serum log(10) vascular endothelial growth factor was positively correlated with renal and cardiac structure, but negatively with creatinine clearance. Serum angiopoietin 1 levels significantly correlated with structural change in both the kidney and the heart and with urinary protein. Thus, the correlation between angiogenic growth factors with both renal and cardiac disease severity is compatible with a possible role for angiogenesis in the early progression of disease in ADPKD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20881939      PMCID: PMC3815472          DOI: 10.1038/ki.2010.355

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  34 in total

1.  Progression of autosomal-dominant polycystic kidney disease in children.

Authors:  G M Fick-Brosnahan; Z V Tran; A M Johnson; J D Strain; P A Gabow
Journal:  Kidney Int       Date:  2001-05       Impact factor: 10.612

2.  Hypoxia and vascular endothelial growth factor acutely up-regulate angiopoietin-1 and Tie2 mRNA in bovine retinal pericytes.

Authors:  Yoon Shin Park; Nan Hee Kim; Inho Jo
Journal:  Microvasc Res       Date:  2003-03       Impact factor: 3.514

3.  The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease.

Authors:  A B Chapman; A Johnson; P A Gabow; R W Schrier
Journal:  N Engl J Med       Date:  1990-10-18       Impact factor: 91.245

4.  Secretion of cytokines and growth factors into autosomal dominant polycystic kidney disease liver cyst fluid.

Authors:  Matthew T Nichols; Elsa Gidey; Tom Matzakos; Rolf Dahl; Greg Stiegmann; Raj J Shah; Jared J Grantham; J Gregory Fitz; R Brian Doctor
Journal:  Hepatology       Date:  2004-10       Impact factor: 17.425

5.  Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort.

Authors:  Arlene B Chapman; Lisa M Guay-Woodford; Jared J Grantham; Vicente E Torres; Kyongtae T Bae; Deborah A Baumgarten; Philip J Kenney; Bernard F King; James F Glockner; Louis H Wetzel; Marijn E Brummer; W Charles O'Neill; Michelle L Robbin; William M Bennett; Saulo Klahr; Gladys H Hirschman; Paul L Kimmel; Paul A Thompson; J Philip Miller
Journal:  Kidney Int       Date:  2003-09       Impact factor: 10.612

6.  Increased renal vascular endothelial growth factor and angiopoietins by angiotensin II infusion is mediated by both AT1 and AT2 receptors.

Authors:  Bishoy Rizkalla; Josephine M Forbes; Mark E Cooper; Zemin Cao
Journal:  J Am Soc Nephrol       Date:  2003-12       Impact factor: 10.121

7.  Plasma and platelet-derived vascular endothelial growth factor and angiopoietin-1 in hypertension: effects of antihypertensive therapy.

Authors:  S K Nadar; A D Blann; G Y H Lip
Journal:  J Intern Med       Date:  2004-10       Impact factor: 8.989

8.  Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1.

Authors:  D Ravine; R N Gibson; R G Walker; L J Sheffield; P Kincaid-Smith; D M Danks
Journal:  Lancet       Date:  1994-04-02       Impact factor: 79.321

9.  Ambulatory blood pressure correlates with renal volume and number of renal cysts in children with autosomal dominant polycystic kidney disease.

Authors:  Tomás Seeman; Jirí Dusek; Hana Vondrichová; Martin Kyncl; Ulrike John; Joachim Misselwitz; Jan Janda
Journal:  Blood Press Monit       Date:  2003-06       Impact factor: 1.444

10.  Renal, cardiovascular and hormonal characteristics of young adults with autosomal dominant polycystic kidney disease.

Authors:  S B Harrap; D L Davies; A M Macnicol; A F Dominiczak; R Fraser; A F Wright; M L Watson; J D Briggs
Journal:  Kidney Int       Date:  1991-09       Impact factor: 10.612

View more
  14 in total

1.  Angiogenic growth factor level correlates with structural and functional changes in ADPKD.

Authors:  Susan J Allison
Journal:  Nat Rev Nephrol       Date:  2011-01       Impact factor: 28.314

Review 2.  The hallmarks of cancer: relevance to the pathogenesis of polycystic kidney disease.

Authors:  Tamina Seeger-Nukpezah; Daniel M Geynisman; Anna S Nikonova; Thomas Benzing; Erica A Golemis
Journal:  Nat Rev Nephrol       Date:  2015-04-14       Impact factor: 28.314

3.  The association of serum angiogenic growth factors with renal structure and function in patients with adult autosomal dominant polycystic kidney disease.

Authors:  Melahat Coban; Ayca Inci
Journal:  Int Urol Nephrol       Date:  2018-04-13       Impact factor: 2.370

4.  A rare case of amyloid light-chain amyloidosis with bilateral perirenal hematoma shortly after initiation of peritoneal dialysis.

Authors:  Toshiya Yamamoto; Hiroyuki Kadoya; Eriko Urabe; Seiji Itano; Tamaki Sasaki; Naoki Kashihara
Journal:  CEN Case Rep       Date:  2021-01-07

Review 5.  Predictors of autosomal dominant polycystic kidney disease progression.

Authors:  Robert W Schrier; Godela Brosnahan; Melissa A Cadnapaphornchai; Michel Chonchol; Keith Friend; Berenice Gitomer; Sandro Rossetti
Journal:  J Am Soc Nephrol       Date:  2014-06-12       Impact factor: 10.121

Review 6.  Angiogenesis and autosomal dominant polycystic kidney disease.

Authors:  Jennifer L Huang; Adrian S Woolf; David A Long
Journal:  Pediatr Nephrol       Date:  2012-09-19       Impact factor: 3.714

7.  Effect of pravastatin on total kidney volume, left ventricular mass index, and microalbuminuria in pediatric autosomal dominant polycystic kidney disease.

Authors:  Melissa A Cadnapaphornchai; Diana M George; Kim McFann; Wei Wang; Berenice Gitomer; John D Strain; Robert W Schrier
Journal:  Clin J Am Soc Nephrol       Date:  2014-04-10       Impact factor: 8.237

8.  Bioactive lipid mediators in polycystic kidney disease.

Authors:  Jelena Klawitter; Jost Klawitter; Kim McFann; Alexander T Pennington; Kaleab Z Abebe; Godela Brosnahan; Melissa A Cadnapaphornchai; Michel Chonchol; Berenice Gitomer; Uwe Christians; Robert W Schrier
Journal:  J Lipid Res       Date:  2013-12-16       Impact factor: 5.922

Review 9.  Therapeutic advances in ADPKD: the future awaits.

Authors:  Ivana Capuano; Pasquale Buonanno; Eleonora Riccio; Maria Amicone; Antonio Pisani
Journal:  J Nephrol       Date:  2021-05-19       Impact factor: 3.902

10.  Vascular disruption and the role of angiogenic proteins after spinal cord injury.

Authors:  Michelle T L Ng; Anthea T Stammers; Brian K Kwon
Journal:  Transl Stroke Res       Date:  2011-10-13       Impact factor: 6.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.